"In an industry where demand is stronger than ever and expectations had increased into the print, a $50mn raise to ‘24 EBITDA guidance was not enough," one analyst wrote.
April jobs report to be released Friday at 8:30 a.m. Consensus among economists suggests employment growth may slightly dip from March, but overall outlook remains optimistic. Market response likely to be positive based on previous trends.
BD reports Q2 sales of $5.04 billion, up 4.6% Y/Y. BD Medical, Life Sciences, and Interventional segments show growth. Guidance was raised for 2024 sales, and EPS was adjusted. William Blair rates BDX shares Outperform.
Hawtin also highlighted potential demand issues stemming from Tesla's aggressive price cuts, which have led to a drop in used car values and could result in higher leasing costs.